ScoreWhy is Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -4.57% and Operating profit at 6.69% over the last 5 years
- PRE-TAX PROFIT(Q) At CNY 250.78 MM has Fallen at -75.14%
- NET PROFIT(Q) At CNY 224.56 MM has Fallen at -74.33%
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.33 times
2
With ROE of 39.69%, it has a very attractive valuation with a 3.31 Price to Book Value
- Over the past year, while the stock has generated a return of 35.81%, its profits have risen by 285.1% ; the PEG ratio of the company is 0
- At the current price, the company has a high dividend yield of 2.5
3
Market Beating Performance
- The stock has generated a return of 35.81% in the last 1 year, much higher than market (China Shanghai Composite) returns of 22.49%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
15.82%
0.39
31.64%
China Shanghai Composite
21.43%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-5.98%
EBIT Growth (5y)
7.66%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
0.85
Tax Ratio
15.22%
Dividend Payout Ratio
173.10%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.54%
ROE (avg)
15.94%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
2.90
EV to EBIT
23.08
EV to EBITDA
20.80
EV to Capital Employed
3.46
EV to Sales
4.04
PEG Ratio
NA
Dividend Yield
9.74%
ROCE (Latest)
15.01%
ROE (Latest)
28.74%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -6.5% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -22.73 %
DEBTORS TURNOVER RATIO(HY)
Highest at 2.84 times
NET SALES(Q)
Highest at CNY 1,515.2 MM
OPERATING PROFIT(Q)
Highest at CNY 461.48 MM
OPERATING PROFIT MARGIN(Q)
Highest at 30.46 %
-21What is not working for the Company
NET PROFIT(HY)
At CNY 402.64 MM has Grown at -77.63%
OPERATING CASH FLOW(Y)
Lowest at CNY 569.31 MM
NET SALES(HY)
At CNY 2,762.68 MM has Grown at -11.85%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.12 times
INTEREST(Q)
Highest at CNY 3 MM
Here's what is working for Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
Net Sales
Highest at CNY 1,515.2 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Net Sales
At CNY 1,515.2 MM has Grown at 23.25%
over average net sales of the previous four periods of CNY 1,229.33 MMMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 461.48 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 30.46 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Debt-Equity Ratio
Lowest at -22.73 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 2.84 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -6.5% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.
Net Profit
At CNY 402.64 MM has Grown at -77.63%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 3 MM has Grown at 29.46%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Inventory Turnover Ratio
Lowest at 1.12 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Operating Cash Flow
Lowest at CNY 569.31 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Interest
Highest at CNY 3 MM
in the last five periods and Increased by 29.46% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
